TriSalus Life Sciences
TLSI
9 hedge funds and large institutions have $699K invested in TriSalus Life Sciences in 2023 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 4 closing their positions.
75% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 4
50% more funds holding
Funds holding: 6 → 9 (+3)
45.82% less ownership
Funds ownership: 46.34% → 0.52% (-46%)
93% less capital invested
Capital invested by funds: $9.48M → $699K (-$8.78M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CWM
Connecticut Wealth Management
Farmington,
Connecticut
|
+$468K |
| 2 |
AC
Anson Capital
Tyrone,
Georgia
|
+$287K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$204K |
| 4 |
Morgan Stanley
New York
|
+$9.31K |
| 5 |
GWSG
GPS Wealth Strategies Group
Centennial,
Colorado
|
+$5.38K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$7.34M |
| 2 |
SIA
SkyView Investment Advisors
Shrewsbury,
New Jersey
|
-$1.57M |
| 3 |
MC
Meteora Capital
Boca Raton,
Florida
|
-$362K |
| 4 |
PCM
PenderFund Capital Management
Vancouver,
British Columbia, Canada
|
-$25K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CWM
1
Connecticut Wealth Management
Farmington,
Connecticut
| $293K | +$468K | +57,188 | New |
|
|
AC
2
Anson Capital
Tyrone,
Georgia
| $179K | +$287K | +35,005 | New |
|
|
3
UBS Group
Zurich,
Switzerland
| $128K | +$204K | +24,910 | +113,227% |
|
4
Geode Capital Management
Boston,
Massachusetts
| $88.3K | – | – | – |
|
|
5
Morgan Stanley
New York
| $5.82K | +$9.31K | +1,137 | New |
|
|
GWSG
6
GPS Wealth Strategies Group
Centennial,
Colorado
| $3.36K | +$5.38K | +657 | New |
|
|
WAM
7
Wolverine Asset Management
Chicago,
Illinois
| $2.12K | +$3.4K | +415 | New |
|
|
DM
8
Deerfield Management
New York
| $5 | +$8 | +1 | New |
|
9
Wells Fargo
San Francisco,
California
| $5 | +$8 | +1 | New |
|
|
MF
10
Magnetar Financial
Evanston,
Illinois
| – | -$7.34M | -700,000 | Closed |
|
|
SIA
11
SkyView Investment Advisors
Shrewsbury,
New Jersey
| – | -$1.57M | -150,000 | Closed |
|
|
MC
12
Meteora Capital
Boca Raton,
Florida
| – | -$362K | -34,554 | Closed |
|
|
PCM
13
PenderFund Capital Management
Vancouver,
British Columbia, Canada
| – | -$25K | -1,768 | Closed |
|
TLSI Hedge Fund Activity: Q3 2023 in Review
9 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in TriSalus Life Sciences (TLSI) for Q3 2023, worth a combined $699K — down 93% from $9.48M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new TLSI positions and 4 closed out — a net gain of 3 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Connecticut Wealth Management, opening a new position worth an estimated $468K. The largest seller was Magnetar Financial, exiting entirely with an estimated $7.34M sold.
- 9 institutional investors held TriSalus Life Sciences (TLSI) as of Q3 2023, up from 6 in Q2 2023.
- Funds reported $699K of TriSalus Life Sciences stock for Q3 2023, down 93% quarter-over-quarter.
- 7 funds opened new TriSalus Life Sciences positions in Q3 2023 and 4 closed out, a net change of +3 holders.
- The largest TriSalus Life Sciences buyer in Q3 2023 was Connecticut Wealth Management, an estimated $468K added.
- The largest TriSalus Life Sciences seller in Q3 2023 was Magnetar Financial, an estimated $7.34M sold.
Based on aggregated 13F filings for Q3 2023.